supp.fit

Vitamin B12, Vitamin B6, Zinc and Riboflavin: study protocols

8 study groups took Vitamin B12 together with Vitamin B6, Zinc and Riboflavin. These are the doses the studies gave. They are not a recommendation.

Vitamin B12: what the research found →

Dose per serving from research: Vitamin B12

8 study groups in 8 studies say how much Vitamin B12 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 mcg to 5 mcg and 5 mcg to 10 mcg, 38% of 8 study groups each.

Daily doseStudy groups
1 mcg or less
1
1 mcg to 2.5 mcg
1
2.5 mcg to 5 mcg
3
5 mcg to 10 mcg
3

Dose per serving from research: Vitamin B6

8 study groups in 8 studies say how much Vitamin B6 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 38% of 8 study groups.

Daily doseStudy groups
500 mcg or less
1
500 mcg to 1 mg
1
1 mg to 2.5 mg
3
2.5 mg to 5 mg
2
5 mg to 10 mg
1

Dose per serving from research: Zinc

8 study groups in 8 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 63% of 8 study groups.

Daily doseStudy groups
5 mg to 10 mg
2
10 mg to 25 mg
5
25 mg to 50 mg
1

Dose per serving from research: Riboflavin

8 study groups in 8 studies say how much Riboflavin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 63% of 8 study groups.

Daily doseStudy groups
500 mcg or less
1
500 mcg to 1 mg
0
1 mg to 2.5 mg
5
2.5 mg to 5 mg
1
5 mg to 10 mg
1

Commonly used together

8 of 8 study groups took Vitamin B12, Vitamin B6, Zinc and Riboflavin with something else. Shown: what 3 or more different studies gave. The 10 most common of 11.

What was given together, not what works together.

Taken withStudy groups
Folic Acid
6
Thiamine
6
Iron
5
Vitamin A
5
Vitamin D
5
Vitamin E
5
Copper
4
Iodine
4
Niacin
4
Vitamin C
4

8 study groups

Study
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
2 mcg1.7 mg20 mg1.6 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
2.6 mcg2.2 mg30 mg1.8 mg——
Effect of zinc plus multivitamin supplementation on growth in school children
2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years
10 mcg1 mg20 mg3 mg26 weeks70
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
10 mcg10 mg20 mg10 mg120 days—
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
5.2 mcg2.6 mg10 mg1.8 mg—870
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies
0.9 mcg500 mcg10 mg500 mcg36 weeks130
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
2.6 mcg1.9 mg15 mg1.4 mg12 weeks105
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
5 mcg3 mg12.5 mg2.4 mg60 days52